Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating income	$ 2,194	$ 2,546
Operating expenses
Research and development expenses	(16,037)	(12,223)
Sales and marketing expenses	(434)	(464)
General and administrative expenses	(6,889)	(6,630)
Total Operating expenses	(23,359)	(19,317)
Loss from operations	(21,165)	(16,771)
Financial income(expenses)	605	152
Loss before taxes	(20,561)	(16,619)
Income tax (expense)	0	(87)
Net loss	(20,561)	(16,706)
Foreign currency translation differences, net of taxes	3,666	(1,933)
Actuarial gains (losses) on employee benefits, net of taxes	(82)	24
Total comprehensive loss	$ (16,977)	$ (18,615)
Basic Net loss per share attributable to shareholders	$ (0.22)	$ (0.3)
Weighted average number of shares outstanding used in computing per share amounts:	93,970,598	54,932,192
Diluted Net loss per share attributable to shareholders	$ (0.22)	$ (0.3)
Weighted average number of shares outstanding used in computing per share amounts:	93,970,598	54,932,192